Cystic fibrosis (CF) is an autosomal recessive genetic disease, which is characterized by the production of thick mucus in exocrine glands. The main cause for morbidity and mortality in CF patients is respiratory failure. The gastrointestinal system is also commonly affected. Urologic manifestations of CF include infertility and azoospermia, nephrolithiasis, and stress urinary incontinence. In this report, we describe a 33-year-old male, who presented with recurrent urinary retention due to prostatic enlargement despite his young age. After transurethral resection, the voiding problems resolved. Histopathological examination, however, revealed a severe pseudocystic mucoid degeneration of the prostatic matrix as a cause of his subvesical obstruction. Although these structural changes are most probably due to his underlying disease, detailed histologic features have not been described in the literature.

Keywords:
Bladder outlet obstruction, Mucoid degeneration, Prostatic enlargement, Cystic fibrosis, Urinary retention
1.
Salvatore D, Buzzetti R, Baldo E, Forneris MP, Lucidi V, Manunza D, Marinelli I, Messore B, Neri AS, Raia V, Furnari ML, Mastella G: An overview of international literature from cystic fibrosis registries. Part 3. Disease incidence, genotype/phenotype correlation, microbiology, pregnancy, clinical complications, lung transplantation, and miscellanea. J Cyst Fibros 2011;10:71-85.
2.
Oates RD: Clinical evaluation of the infertile male with respect to genetic etiologies. Syst Biol Reprod Med 2011;57:72-77.
3.
Sakamoto H, Yajima T, Suzuki K, Ogawa Y: Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutation associated with a congenital bilateral absence of vas deferens. Int J Urol 2008;15:270-271.
4.
Havasi V, Keiles S, Hambuch T, Sorscher EJ, Kammesheidt A: The role of the F508C mutation in congenital bilateral absence of the vas deferens. Genet Med 2008;10:910-914.
5.
Blackwell K, Malone PS, Denny A, Connett G, Maddison J: The prevalence of stress urinary incontinence in patients with cystic fibrosis: an under-recognized problem. J Pediatr Urol 2005;1:5-9.
6.
Perez-Brayfield MR, Caplan D, Gatti JM, Smith EA, Kirsch AJ: Metabolic risk factors for stone formation in patients with cystic fibrosis. J Urol 2002;167:480-484.
7.
Quon BS, Mayer-Hamblett N, Aitken ML, Smyth AR, Goss CH: Risk factors for chronic kidney disease in adults with cystic fibrosis. Am J Respir Crit Care Med 2011;184:1147-1152.
© 2015 S. Karger AG, Basel
2015
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.